Patient Voices in Value-Based Cancer Care: Priorities for the Biden Administration

April 2021

The Biden administration has an opportunity to prioritize patient perspectives in innovative value-based payment models for oncology by incorporating meaningful patient-reported measures (PRMs) and patient-reported performance measures (PR-PMs).

In a new perspective article in the Journal of Clinical Pathways, the National Pharmaceutical Council, Discern Health, and Drs. Mark McClellan and Ethan Basch draw from previous research on the use of PR-PMs in oncology to outline opportunities and recommendations for the Centers for Medicare & Medicaid Services to look beyond prior value-based payment models to accelerate appropriate use of PRMs and PR-PMs and elevate patient voices in future oncology value-based payment programs.

Learn More

New Report: Recommendations for Patient and Family Engagement in Measure Development

Harnessing the stories, ideas, and innovations of patient and caregiver partners is the key to making measurement meaningful. With support from the Patient-Centered Outcomes Research Institute (PCORI)...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO